PLX · Protalix BioTherapeutics, Inc. · Analyst Estimates
Market Cap
$212.71M
Shares
80.57M
Analyst Estimates
Compare analyst forecasts for Protalix BioTherapeutics, Inc. across metrics and forecast periods.
Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.
Only independently verified consensus published through the company's investor-relations sources is available.
Consensus not yet available
Only independently verified consensus published through the company's investor-relations sources is available.
Key facts
CIK
1006281
CUSIP
74365A309
13F (30d)
41 filings
41 filers
Visit website
Investor relations